Showing results (41-50 of 2,154) with videos related to
Sort By:
Pageof 216
Journal of Environmental Management|May 19, 2020
Water quality perceptions and private well management: The role of perceived risks, worry and controlG Schuitema, T Hooks, F McDermottThe American Journal of Psychiatry|April 11, 1975
Psychotherapy: historical roots, universal elements, and cultural variationsW S Tseng, J F McdermottExpert Opinion on Biological Therapy|April 23, 2004
Application of IL-2 and other cytokines in renal cancerDavid F McDermott, Michael B AtkinsClinical Advances in Hematology & Oncology : H&O|July 28, 2017
Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancerDavid J Einstein, David F McDermottSeminars in Oncology|October 19, 2006
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of responseDavid F McDermott, Michael B AtkinsCancer|September 19, 2019
Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinomaCharlene M Mantia, David F McDermottJournal for Immunotherapy of Cancer|August 27, 2025
How can we increase the value of clinical trials with immunotherapy?Michael B Atkins, David F McdermottAcademic Medicine : Journal of the Association of American Medical Colleges|December 11, 1991
Retraining faculty for the problem-based curriculum at the University of Hawaii, 1989-1991J F McDermott, A S AndersonClinical Therapeutics|March 10, 2015
Cytotoxic T-lymphocyte antigen-4 blockade in melanomaElizabeth I Buchbinder, David F McDermottSeminars in Oncology|August 27, 2013
Immune therapy for kidney cancer: a second dawn?David F McDermott, Michael B AtkinsPageof 216